You have 9 free searches left this month | for more free features.

CpG1018

Showing 1 - 25 of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • Alzheimer Dementia
  • CpG1018
  • Placebo
  • (no location specified)
Jan 3, 2023

COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • SARS-CoV-2 inactivated vaccine
  • Semarang, Central Java, Indonesia
  • +1 more
Aug 8, 2022

Plague, Pneumonic, Plague, Vaccine-Preventable Diseases Trial in United States (rF1V vaccine and CpG 1018® adjuvant, rF1V

Recruiting
  • Plague, Pneumonic
  • +2 more
  • rF1V vaccine and CpG 1018® adjuvant
  • rF1V vaccine
  • Huntsville, Alabama
  • +4 more
Aug 16, 2022

COVID-19 Trial in Kyiv, Vinnitsa (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Havrix, Placebo; 0.9% saline)

Terminated
  • COVID-19
  • CpG 1018/Alum-adjuvanted SCB-2019 vaccine
  • +2 more
  • Kyiv, Ukraine
  • +3 more
May 19, 2022

COVID-19 Trial in Taiyuan, Chengdu (Candidate Vaccine, SCB-2019, Placebo)

Active, not recruiting
  • COVID-19
  • Candidate Vaccine, SCB-2019
  • Placebo
  • Taiyuan, Shanxi, China
  • +1 more
Feb 22, 2022

COVID-19 Trial in Nedlands (SCB-2019, SCB-2019 with AS03 adjuvant, SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant)

Completed
  • COVID-19
  • SCB-2019
  • +3 more
  • Nedlands, Western Australia, Australia
    Linear Clinical Research Ltd
Feb 17, 2022

COVID-19 Trial in Semarang, Makassar, Padang (SARS-CoV-2 protein subunit recombinant vaccine, )

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • placebo
  • Semarang, Central Java, Indonesia
  • +2 more
Aug 8, 2022

COVID-19 Trial in Indonesia (COVID-19 Protein Subunit Recombinant Vaccine, Active Comparator)

Recruiting
  • COVID-19
  • COVID-19 Protein Subunit Recombinant Vaccine
  • Active Comparator
  • Semarang, Central Java, Indonesia
  • +3 more
Jun 26, 2022

COVID-19 Trial in Worldwide (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Placebo; 0.9% saline, SCB-2019 vaccine)

Recruiting
  • COVID-19
  • CpG 1018/Alum-adjuvanted SCB-2019 vaccine
  • +3 more
  • Alken, Belgium
  • +30 more
Feb 7, 2022

Shingles, Herpes Zoster, Vaccine-Preventable Diseases Trial in Australia (Z-1018, Shingrix)

Recruiting
  • Shingles
  • +2 more
  • Z-1018
  • Shingrix
  • Blacktown, New South Wales, Australia
  • +3 more
Feb 8, 2022

SARS-CoV 2 Trial in Montréal, Québec (Intramuscular Vaccine)

Completed
  • SARS-CoV 2
  • Intramuscular Vaccine
  • Montréal, Quebec, Canada
  • +1 more
Apr 4, 2022

Covid-19, SARS Pneumonia, Pneumonia, Viral Trial in Bangkok (Normal Saline, NDV-HXP-S vaccine)

Recruiting
  • Covid-19
  • +3 more
  • Normal Saline
  • NDV-HXP-S vaccine
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Mar 13, 2022

SARS-CoV-2 Virus Infection Trial in United Kingdom (VLA2001, AZD1222, VLA2001 - adolescent part)

Active, not recruiting
  • SARS-CoV-2 Virus Infection
  • VLA2001
  • +3 more
  • Barnsley, United Kingdom
  • +30 more
Oct 17, 2022

COVID-19 Trial (candidate vaccine, SCB-2020S)

Withdrawn
  • COVID-19
  • candidate vaccine, SCB-2020S
  • (no location specified)
Sep 2, 2021

SARS-CoV-2 Infection Trial in Groningen, Utrecht, Auckland (VLA2001)

Active, not recruiting
  • SARS-CoV-2 Infection
  • VLA2001
  • Groningen, Netherlands
  • +3 more
Jan 17, 2023

COVID-19 Trial in Cali (VLA 2001)

Not yet recruiting
  • COVID-19
  • VLA 2001
  • Cali, Valle, Colombia
    Centro de Estudios en Infectología Pediátrica
Sep 15, 2022

COVID-19 Trial in Taipei (MVC-COV1901)

Completed
  • COVID-19
  • MVC-COV1901
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 27, 2022

COVID-19 Disease, SARS Pneumonia, Pneumonia, Viral Trial in Hanoi, Thai Binh (COVIVAC, Phosphate-buffered saline)

Recruiting
  • COVID-19 Disease
  • +3 more
  • COVIVAC
  • Phosphate-buffered saline
  • Hanoi, Vietnam
  • +1 more
Apr 1, 2021

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

SARS-CoV-2 Virus Infection Trial in New Zealand (VLA2001)

Active, not recruiting
  • SARS-CoV-2 Virus Infection
  • VLA2001
  • Auckland, Birkenhead, New Zealand
  • +7 more
Feb 3, 2022

Covid19 Trial in Porto Alegre, Rio De Janeiro, Natal (ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca), CoronaVac (Sinovac

Not yet recruiting
  • Covid19
  • ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca)
  • +2 more
  • Porto Alegre, Rio De Grande Do Sul, Brazil
  • +2 more
Oct 19, 2021

End Stage Renal Disease on Dialysis (Diagnosis) Trial in United States (HEPLISAV-B®)

Unknown status
  • End Stage Renal Disease on Dialysis (Diagnosis)
  • Bloomfield, Connecticut
  • +19 more
Dec 14, 2020

Severe Aortic Valve Stenosis Trial in Egypt, Lebanon, Saudi Arabia (Aortic valve replacement)

Not yet recruiting
  • Severe Aortic Valve Stenosis
  • Aortic valve replacement
  • Aswan, Egypt
  • +6 more
May 4, 2023

Tumors Trial in Pamplona, Madrid (Urelumab + Nivolumab)

Unknown status
  • Neoplasms
  • Urelumab + Nivolumab
  • Pamplona, Navarra, Spain
  • +1 more
Jan 2, 2019

Aging Trial in San Mateo (Plasma Transfusion)

Unknown status
  • Aging
  • Plasma Transfusion
  • San Mateo, California
    The Infusion Center & Clinic
Jan 14, 2018